These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 14616414)
1. Histamine H2-receptor antagonists have no clinically significant effect on the steady-state pharmacokinetics of voriconazole. Purkins L; Wood N; Kleinermans D; Nichols D Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):51-5. PubMed ID: 14616414 [TBL] [Abstract][Full Text] [Related]
2. No clinically significant pharmacokinetic interactions between voriconazole and indinavir in healthy volunteers. Purkins L; Wood N; Kleinermans D; Love ER Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):62-8. PubMed ID: 14616416 [TBL] [Abstract][Full Text] [Related]
3. Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration. Purkins L; Wood N; Ghahramani P; Love ER; Eve MD; Fielding A Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):37-44. PubMed ID: 14616412 [TBL] [Abstract][Full Text] [Related]
4. Effect of omeprazole on the steady-state pharmacokinetics of voriconazole. Wood N; Tan K; Purkins L; Layton G; Hamlin J; Kleinermans D; Nichols D Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):56-61. PubMed ID: 14616415 [TBL] [Abstract][Full Text] [Related]
5. No clinically significant effect of erythromycin or azithromycin on the pharmacokinetics of voriconazole in healthy male volunteers. Purkins L; Wood N; Ghahramani P; Kleinermans D; Layton G; Nichols D Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):30-6. PubMed ID: 14616411 [TBL] [Abstract][Full Text] [Related]
6. Effect of food on the pharmacokinetics of multiple-dose oral voriconazole. Purkins L; Wood N; Kleinermans D; Greenhalgh K; Nichols D Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):17-23. PubMed ID: 14616409 [TBL] [Abstract][Full Text] [Related]
7. Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety. Purkins L; Wood N; Greenhalgh K; Allen MJ; Oliver SD Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):10-6. PubMed ID: 14616408 [TBL] [Abstract][Full Text] [Related]
8. Voriconazole does not affect the steady-state pharmacokinetics of digoxin. Purkins L; Wood N; Kleinermans D; Nichols D Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):45-50. PubMed ID: 14616413 [TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics and safety of intravenous voriconazole - a novel wide-spectrum antifungal agent. Purkins L; Wood N; Greenhalgh K; Eve MD; Oliver SD; Nichols D Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):2-9. PubMed ID: 14616407 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic interaction between voriconazole and efavirenz at steady state in healthy male subjects. Liu P; Foster G; LaBadie RR; Gutierrez MJ; Sharma A J Clin Pharmacol; 2008 Jan; 48(1):73-84. PubMed ID: 18025525 [TBL] [Abstract][Full Text] [Related]
11. Steady-state pharmacokinetic and safety profiles of voriconazole and ritonavir in healthy male subjects. Liu P; Foster G; Gandelman K; LaBadie RR; Allison MJ; Gutierrez MJ; Sharma A Antimicrob Agents Chemother; 2007 Oct; 51(10):3617-26. PubMed ID: 17646413 [TBL] [Abstract][Full Text] [Related]
12. A pharmacokinetic and pharmacodynamic interaction study between nebivolol and the H2-receptor antagonists cimetidine and ranitidine. Kamali F; Howes A; Thomas SH; Ford GA; Snoeck E Br J Clin Pharmacol; 1997 Feb; 43(2):201-4. PubMed ID: 9131955 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens. Purkins L; Wood N; Ghahramani P; Greenhalgh K; Allen MJ; Kleinermans D Antimicrob Agents Chemother; 2002 Aug; 46(8):2546-53. PubMed ID: 12121931 [TBL] [Abstract][Full Text] [Related]
15. Effect of cimetidine and ranitidine on pharmacokinetics and pharmacodynamics of a single dose of dofetilide. Abel S; Nichols DJ; Brearley CJ; Eve MD Br J Clin Pharmacol; 2000 Jan; 49(1):64-71. PubMed ID: 10606839 [TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacokinetics of voriconazole administered orally as either crushed or whole tablets. Dodds Ashley ES; Zaas AK; Fang AF; Damle B; Perfect JR Antimicrob Agents Chemother; 2007 Mar; 51(3):877-80. PubMed ID: 17145785 [TBL] [Abstract][Full Text] [Related]
17. Potent cytochrome P450 2C19 genotype-related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir. Mikus G; Schöwel V; Drzewinska M; Rengelshausen J; Ding R; Riedel KD; Burhenne J; Weiss J; Thomsen T; Haefeli WE Clin Pharmacol Ther; 2006 Aug; 80(2):126-35. PubMed ID: 16890574 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and short-term safety of etravirine in combination with fluconazole or voriconazole in HIV-negative volunteers. Kakuda TN; Van Solingen-Ristea R; Aharchi F; Smedt GD; Witek J; Nijs S; Vyncke V; Hoetelmans RM J Clin Pharmacol; 2013 Jan; 53(1):41-50. PubMed ID: 23400742 [TBL] [Abstract][Full Text] [Related]